You are on page 1of 5

IMMUNOLOGY RECALLS

1. ASO titer and Anti-DNAse be are used for 8. Stages of syphilis TREPONEMES -> REITER
detecting strep infection 1. Primary: hard chancre STRAIN
(soft chancre: H. ducreyi)  NICHOL STRAIN -> fixed to slides
2. Major sites of infection with Group A strep are 2. Secondary: condylomata lata
the upper respi tract and skin with pharyngitis 3. Latent: absence of clinical symptoms
and impetigo being the most common 4. Tertiary: gummas, neurosyphilis

3. Streptococcal Antigens/extracellular products 9. Test for Syphilis


1. SLO – Oxygen labile, stab on BAP, ASO A. Nontreponemal
2. SLS - No antibodies detected - detects an using cardiolipin (readin or
3. HS – Antihyaluronidase, ASH test reaginic antibody)
4. SK – Anti-Streptokinase, ASK test - flocculation is the result of the reaction
5. DNAse – Anti-DNAse, Anti-DNAse Test bet. regain and cardiolipin
6. NADase – Anti-NADase, Anti-NADase test - VDRL, RPR, TRUST, USR, RST
10. Components of the Immune System
4. ASO Titer A. Nonspecific defense mechanisms
- ASO is oxygen labile hemolysin that can a. First line of defense
lyse RBC by binding to chole in the RBC  Skin
membrane  Mucus memb
- Titer bigns to increase ~7days after  Skin secretions
infection, peaks after 4-6 weeks b. Second line of defense
- Based on neutralization of hemolytic  Phagocytic WBC
activity of SO  Antimicrobial prot
- NORMAL : 166 Todd units  Inflammatory response
- MOD ELEV: <240 Todd units for adults B. Specific defense mechanisms
<320 Todd units for children a. Third line of defense
B. Treponemal  Cellular: Lymphocytes
5. Anti-DNAse B -detects ab-directed against T. pallidum  Humoral: Antibodies
- Appears earlier than ASO in strep against specific trep ag
pharyngitis - usually becomes positive before nontrep
- Based on neutralization tests
- Measured by effect on DNA-methyl green - once an individual becomes reactive,
conjugate, positive result indicates colorless, individual remains so for life
since the conjugate will be hydrolyzed by - fewer false +, cross reactivity seen with
the DNA other nontrep diseases
a. TPI Test
6. Streptozyme  If >50% immobilized: POSITIVE
- Detects many streptococcal anitgens: SL,  If <20% immobilized:
SK, HS, DNAse, NADase NEGATIVE
 20-50%: DOUBTFUL
7. Syphilis b. FTA-ABE ’
- caused by T. pallidum  Heat inactivated, prepared with a 11. Papain cleaves at the hinge, separating fragments
- Wasserman test is the first diagnostic blood test sorbent consisting of into 3
NONPATHOGENIC
IMMUNOLOGY RECALLS
12. Pepsin cuts below the disulfide bond leaving one - Assoc. with increased likelihood to develop
unit of 2 partial heavy chains and 2 light chains clin sig disease activity with worse 24. CGD
all attached with a disulfide bond prognosis - Morphologically normal but functionally
13. Urea and mercaptoethanol digestion removes - Anti-CCP and RF = specificity of 98-100 -> abnormal bc of enzyme deficiency that
ALL disulfide bonds leaving free units of light more accurate diagnosis of RA result results in an inability to degranulate,
and heavy chains 19. 2 types of light chains: Kappa and lambda causing inhibited bactericidal function
25. Antithyroid peroxidase is usually found in a
14. IgG agglutinates rbcs after anti-human globulin is 20. Albumin is the highest concentration in serum patient with Hashimoto’s thyroiditis
added to the tube
21. Igg is the highest concentration in HASHIMOTO’S THYROIDITIS
15. IN VIVO – Direct Coombs test immunoglobulins - Lymphocytic infiltration
- Destruction of the thyroid glands
16. RHEUMATOID ARTHRITIS - Anti-thyroid peroxidase ab or Anti-
- Affects synovial membrane of multiple joints microsomal antibodies
- Characterized by the presence of an autoab - Anti-thyroglobulin antibodies
called RF which is most often of IgM class and
is directed against the Fc portion of IgG 26. Features of SLE
- Found in px with other connective tissue disease - Positive ANA
such as SLE, Sjogren’s syndrome, scleroderma 22. Late steps of complement activation and - Circulating immune complexes
and mixed CT disease formation of the MAC results in cell lysis - Elevated ESR
- Found in 5% of healthy individuals and 10-25% - Decreased serum complement
of those >65 years of age -> not a definitive
parameter to diagnose arthritis SLE
- Thrives in cold temperature because IgM -characterized by presence of ANA
- CCP is the most highly specific indicator for - immune response directed against a broad range
rheumatoid arthritis of target antigens, as the typical px has an
average of 3 circulating autoantibodies
17. RF test - immunoregulation is also compromised as T reg
- Agglutination using charcoal of latext cells seem to be more sensitive to apoptosis
particles
- Tests detect the IgM isotype (75%) only, not
IgG and IgA isotypes
- Sheep agglutination
- RF latext agglutination
 POS: titer of 80 or greater
 W. POS: titer of 20-40 23. Chediak Higashi
 NEG: no agg of 1:20 - Both morphologically and functionally
18. Anti-CCP abnormal leukocytes
- 20-30% of RF negative patients are positive - WBCs unable to degranulate and kill
for anti-CCP -> higher speci invading bacteria
- Presence of anti-CCP precedes onset of RA - Abnormal fusion of primary and secondary
by several years, making it a better marker neutrophilic granules
for early disease - Large gray-green POD positive granules in
the cytoplasm of wbc
IMMUNOLOGY RECALLS
27. Double- stranded DNA ab are the most specific a. EBV infection results in expression of VCA,  Reactions = allergy
for SLE and their presence is considered EA, and EBNA  Antigens = allergens
diagnostic for SLE b. The correct sequence of the immunologic EBV  May occurs as a systemic disorder
28. Anti-Sm antibody is also diagnostic for SLE bc it response in IM is: VCA, EBNA, VCA-IgM, or as local reaction
is not found in other autoimmune disease, and EA (a misnomer lol)  TWO PHASE REACTION
however it is only found in 7-25% patients with 1. Immediate response is rapid,
this disease 33. HYPERSENSITIVITY REACTIONS 5-30 min after exposure to ag
29. APC include macrophages, dendritic cells, B a.
cells and tissue cells.

30. INFECTIOUS MONONUCLEOSIS


- DNA virus
- Herpes virus associated with Burkitt’s
lymphoma and nasopharyngeal carcinoma
- 80-90% of healthy adults have EBV antibodies,
the virus is ubiquitous
- Acute, self-limiting, infectious
- 2-8 weeks as average incubation period
- Affected cells: B Cells having CD21
- Type II Downey cells present on hematologic
examination (an enlarged lymphocyte with
atypical nuclei)

31. HEPATITIS Type I: Immediate 2. Late phase response, 2-8 hrs


later, occurs in 50% of patients,
infiltration of mono, eo, baso,
PMNs
b. Type II: Cytotoxic Hypersensitivity
 Characterized by interaction of
IgG or IGM ab to cell bound
antigen
 Binding results to complement
activation and cytolysis
 Rbc, wbc, plts can be lysed
 Initiated by the interaction
between antibody except IgE and
antigen
 Ab coated cells are lysed by
effector cells such as NK cells and
macrophages
 Occurring in previously sensiti-
 NK cells synthesize a number of
32. Epstein Barr infected B lymphocytes express zed individual triggered by
cytokines involved in the
variety of new antigens encoded by the virus binding of ag to IgE ab on the
modulation of IR
surface of Mast Cells
IMMUNOLOGY RECALLS
 NK destroy target cells through an conversion of RNA to DNA using reverse does not commonly cause infection in
EC non-phagocyte mechanism transcriptase in the initial steps healthy host
reffered to as a cytotoxic reaction c. Nucleic Acid Sequence-Based Amplification is  Chronic infection – if the infective agent is
c. Type III: similar to TMA but only RNA is targeted for not removed by the neutrophils,
d. Type IV: amplification. Applications include detection mononuclear inflammatory cells, initially
and quantitation of HIV and CMV lymphocytes followed by monocytes and
34. CYTOKINES macrophages invade the area
- IL-2 and IL-3: T cell growth factor and 37. Heating serum at 56 degrees is used to inactivate
Multicolony Stimulating Factor; originates complement in several immunological assays. 41. Macrophage and Monocytes are phagocytic cells,
from activated T-cells. IL-22 originates in During heating both heat-labile and heat-stable activated during infection thru the release of
activated T cells as well anticomplementary activity develop. macrophage-activating cytokines (IFN-Y. G-CSF
- IL-2 is adaptice immunity, activates all from T cells). When exposed to an endotoxin, it
clones of T cytotoxic, increases function of 38. B cell disorders rank as the most common releases TN
T and NK cells primary immunodeficiency category (53%)
- IL-3 promotes expansion of early blood cells because the primary function of B cells is to 42. PMNs are the principal leukocyte associated with
differentiating into all known mature cell produce antibody, the major clinical phagocytosis and localized inflammatory
types. manifestation of B cell deficiency is an increased response. It can prolong inflammation by release
- IL-8 originates from macrophages and susceptibility to severe bacterial infections. of soluble substances such as cytokines and
certain types of epithelial cells chemokines
- IL-18 originates from macrophages and IL- 39. Primary immunodeficiencies (PIDs) are rare
19 originates from monocytes genetic disorders of the innate and adaptive 43. Eosinophils are considered a homeostatic
immune system. More than 120 different gene regulator of inflammation, meaning that the
mutations that cause impairment in the eosinophil attempts to suppress an inflammatory
differentiation and function of immune cells have reaction to prevent excessive spread of
been identified, with different degrees of severity. inflammation
PID disorders are predominantly seen (75%) in
children younger than 5 years. This include 44. A nonreactive result must be obtained for both
- IL-1 originates from monocytes, activated Selective, Combined, and Partial Combined HIV-1 and HIV-2, as well as the p24 antigen, in
macrophages, fribroblasts, and dendritic immune deficiency disorders. A deficiency in this order to consider a patient negative for HIV. This
cells grouping is the partial combined immune CDC algorithm allows for earlier detection of
deficiency disorder, WAS infections and overcomes the limitations
associated with the use of the western blot test.
35. Normal ratio of B cells producing kappa chains
40. OTHER TERMINOLOGIES
versus those producing lambda chains is
 Granulomatous – aggregation of many 45. As part of initial screening, an HIV-1/2
approximately 2:1. Anything outside the ratio is
activated macrophage and histiocytes in the antigen/antibody combination immunoassay
an indication of monoclonal gammopathy such as
area, particularly with the formation of should be performed.
MM
multinucleated giant cells
 Purulent or Suppurative – sequence of an 46. An HIV-1/2 antibody differentiation
36. MOLECULAR TESTING
inflammatory reaction that begins with the immunoassay should be used to differentiate a
a. Transcription-Mediated Amplification is an
local accumulation of segmented neu positive screening test.
isothermal assay targeting DNA or RNA but
 Opportunistic – evolution of an infectious
makes RNA as its amplified product
dse in an immunocompromised or 47. HIV-1 NAT testing should only be used to
b. RT-PCR or Nucleic Acid sequencing is the
debilitated host by a bacterial species that resolve any discrepant results between initial
procedure that can be modified to include
IMMUNOLOGY RECALLS
reactive testing and nonreactive follow-up
testing.

48. The purified protein derivative skin test is also


known as a targeted tuberculin testing. This form
of skin testing for Mycobacterium tuberculosis. It
is performed by injecting 0.1 ml of tuberculin
purified protein derivative (PPD) into the inner
surface of the forearm. The result is read 48-72
hours after the intradermal injection to look for
the presence of a lesion greater than or equal to
10 mm in diameter

49. The rapid plasma reagin test (RPR) is not a skin


test. It is a serologic test for venereal disease
(syphillis).

50. QuantiFERON® assay is not a skin test. It is an


interferon-gamma release assay (IGRA)
performed in the laboratory.

51. SPOT TB® assay is not a skin test. It is an


interferon-gamma release assay (IGRA)
performed in the laboratory.

52. Nephelometry directly measures the amount of


light scattered by particles in solution,
turbidimetry measures decrease in incident-light
intensity

You might also like